HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery)

Mathematical Biosciences

Volumn 210, Issue 1, 2007, Pages 60-77

  Brazhnik, Paul ^a   Kohn, Kurt W ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HAUSP; Mathematical models; Mdm2; p53 Ubiquitination; Stress response

Indexed keywords

HAUSP; MDM2; P53 UBIQUITINATION; STRESS RESPONSE;

CYTOLOGY; DYNAMIC RESPONSE; ENZYME ACTIVITY; MATHEMATICAL MODELS; TUMORS;

PROTEINS;

HAUSP ENZYME; PROTEIN MDM2; PROTEIN P53; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID; GENOME; NUMERICAL MODEL; PROTEIN; SILICON; STRESS RESISTANCE; TUMOR;

ARTICLE; CELLULAR STRESS RESPONSE; MATHEMATICAL MODEL; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ENDOPEPTIDASES; HUMANS; KINETICS; MATHEMATICS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 35248821834     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2007.05.005     Document Type: Article

References (92)

1. Michael D., and Oren M. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 3 1 (2003) 49
2. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 6810 (2000) 307
3. Bates S., and Vousden K.H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6 1 (1996) 12
4. Brooks C.L., and Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 15 2 (2003) 164
5. Appella E., and Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268 10 (2001) 2764
6. Xu Y. Regulation of p53 responses by post-translational modifications. Cell Death Differ. 10 4 (2003) 400
7. Iwakuma T., and Lozano G. MDM2, an introduction. Mol. Cancer Res. 1 14 (2003) 993
8. Oliner J.D., et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362 6423 (1993) 857
9. Li M., et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 6881 (2002) 648
10. Moll U.M., and Petrenko O. The MDM2-p53 interaction. Mol. Cancer Res. 1 14 (2003) 1001
11. Shaulsky G., Ben-Ze'ev A., and Rotter V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5 11 (1990) 1707
12. Jimenez G.S., et al. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18 53 (1999) 7656
13. Liang S.H., and Clarke M.F. Regulation of p53 localization. Eur. J. Biochem. 268 10 (2001) 2779
14. Inoue T., et al. Control of p53 nuclear accumulation in stressed cells. FEBS Lett. (2005)
15. O'Brate A., and Giannakakou P. The importance of p53 location: nuclear or cytoplasmic zip code?. Drug. Resist. Updat. 6 6 (2003) 313
16. Clarke A.R., et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 6423 (1993) 849
17. Rodriguez-Caso C., Medina M.A., and Sole R.V. Topology, tinkering and evolution of the human transcription factor network. FEBS J. 272 24 (2005) 6423
18. Kohn K.W., and Pommier Y. Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem. Biophys. Res. Commun. 331 3 (2005) 816
19. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 17 (2005) 2899
20. Li M., et al. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13 6 (2004) 879
21. Lev Bar-Or R., et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl. Acad. Sci. USA 97 21 (2000) 11250
22. Lahav G., et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet. 36 2 (2004) 147
23. Geva-Zatorsky N., et al. Oscillations and variability in the p53 system. Mol. Syst. Biol. 2 (2006) 2006 0033
24. Hamstra D.A., et al. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 66 15 (2006) 7482
25. Hartwell L.H., et al. From molecular to modular cell biology. Nature 402 6761 Suppl. (1999) C47
26. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle(*). Cell Death Differ. 12 9 (2005) 1191
27. Fang S., and Weissman A.M. A field guide to ubiquitylation. Cell Mol. Life Sci. 61 13 (2004) 1546
28. Wilkinson K.D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11 3 (2000) 141
29. Barlev N.A., et al. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8 6 (2001) 1243
30. Le Cam A., et al. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell 127 (2006) 775
31. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30 (1996) 405
32. Brooks C.L., and Gu W. Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 3 7 (2004) 895
33. Xirodimas D.P., Stephen C.W., and Lane D.P. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp. Cell Res. 270 1 (2001) 66
34. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 6630 (1997) 299
35. Mendrysa S.M., and Perry M.E. The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress. Mol. Cell Biol. 20 6 (2000) 2023
36. Everett R.D., et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16 7 (1997) 1519
37. Wood S.A. Dubble or nothing? Is HAUSP deubiquitylating enzyme the final arbiter of p53 levels?. Sci STKE 2002 143 (2002) PE34
38. Gostissa M., et al. Regulation of p53 functions: let's meet at the nuclear bodies. Curr. Opin. Cell Biol. 15 3 (2003) 351
39. Cummins J.M., et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428 6982 (2004) 1 following 486
40. Perry M.E., et al. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90 24 (1993) 11623
41. Stommel J.M., and Wahl G.M. MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo.J. 23 7 (2004) 1547
42. Salomoni P., and Pandolfi P.P. p53 De-ubiquitination: at the edge between life and death. Nat. Cell Biol. 4 6 (2002) E152
43. Yu Z.K., Geyer R.K., and Maki C.G. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene 19 51 (2000) 5892
44. Shirangi T.R., Zaika A., and Moll U.M. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J. 16 3 (2002) 420
45. Yin Y., et al. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 4 6 (2002) 462
46. Scrable H., Sasaki T., and Maier B. DeltaNp53 or p44: priming the p53 pump. Int. J. Biochem. Cell Biol. 37 5 (2005) 913
47. Middeler G., et al. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14 12 (1997) 1407
48. Lai Z., et al. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 276 33 (2001) 31357
49. Fang S., et al. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275 12 (2000) 8945
50. Jardine L.J., and Maki C.G. Stability and ubiquitination of the tumor suppressor protein p53. Methods Mol. Biol. 223 (2003) 27
51. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503
52. Ryan K.M., Phillips A.C., and Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin Cell Biol. 13 3 (2001) 332
53. Li M., et al. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302 5652 (2003) 1972
54. Grossman S.R., et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300 5617 (2003) 342
55. Hicke L., and Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19 (2003) 141
56. Brooks C.L., and Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21 3 (2006) 307
57. Segel I.H. Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (1975), Wiley
58. Schon O., et al. Molecular mechanism of the interaction between MDM2 and p53. J. Mol. Biol. 323 3 (2002) 491
59. Kussie P.H., et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 5289 (1996) 948
60. Daniels F., and Aberty R.A. Physical Chemistry. 3rd ed. (1967), Wiley, New York
61. Saville M.K., et al. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. J. Biol. Chem. 279 40 (2004) 42169
62. Maclachlan T.K., Meng R.D., and El-Deiry W.S. "p53: Twenty Years On" in Trieste, Italy, May 20-22. J. Cell Physiol. 181 2 (1999) 371
63. Ma L., et al. A plausible model for the digital response of p53 to DNA damage. Proc. Natl. Acad. Sci. USA 102 40 (2005) 14266
64. von Dassow G., et al. The segment polarity network is a robust developmental module. Nature 406 6792 (2000) 188
65. Cummins J.M., and Vogelstein B. HAUSP is required for p53 destabilization. Cell Cycle 3 6 (2004) 689
66. Holowaty M.N., et al. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278 48 (2003) 47753
67. Lim S.K., et al. Identification and characterization of murine mHAUSP encoding a deubiquitinating enzyme that regulates the status of p53 ubiquitination. Int. J. Oncol. 24 2 (2004) 357
68. Lai Z., et al. Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proc. Natl. Acad. Sci. USA 99 23 (2002) 14734
69. Vassilev L.T. p53 Activation by small molecules: application in oncology. J. Med. Chem. 48 14 (2005) 4491
70. Vassilev L.T., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 5659 (2004) 844
71. Johnson A.D., et al. lambda Repressor and cro-components of an efficient molecular switch. Nature 294 5838 (1981) 217
72. Gardner T.S., Cantor C.R., and Collins J.J. Construction of a genetic toggle switch in Escherichia coli. Nature 403 6767 (2000) 339
73. Novak B.B., and Tyson J.J. A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230 4 (2004) 563
74. Goldbeter A., and Koshland Jr. D.E. An amplified sensitivity arising from covalent modification in biological systems. Proc. Natl. Acad. Sci. USA 78 11 (1981) 6840
75. Ferrell Jr. J.E. Building a cellular switch: more lessons from a good egg. Bioessays 21 10 (1999) 866
76. Legewie S., et al. Ultrasensitization: switch-like regulation of cellular signaling by transcriptional induction. PLoS Comput. Biol. 1 5 (2005) e54
77. Tyson J.J., Csikasz-Nagy A., and Novak B. The dynamics of cell cycle regulation. Bioessays 24 12 (2002) 1095
78. Brazhnik P., and Tyson J.J. Cell cycle control in bacteria and yeast: a case of convergent evolution?. Cell Cycle 5 5 (2006) 125
79. Saito S., et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278 39 (2003) 37536
80. Ashcroft M., Kubbutat M.H., and Vousden K.H. Regulation of p53 function and stability by phosphorylation. Mol. Cell Biol. 19 3 (1999) 1751
81. Blattner C., et al. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene 18 9 (1999) 1723
82. Dumaz N., and Meek D.W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18 24 (1999) 7002
83. Stommel J.M., and Wahl G.M. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation. Cell Cycle 4 3 (2005)
84. Inoue T., et al. Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents. FEBS Lett. 490 3 (2001) 196
85. Alarcon R., et al. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 59 24 (1999) 6046
86. Maya R., et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes. Dev. 15 9 (2001) 1067
87. Weber J.D., et al. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1 1 (1999) 20
88. Fuchs S.Y., et al. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12 (2006) 2658
89. Ashcroft M., Taya Y., and Vousden K.H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell Biol. 20 9 (2000) 3224
90. Hengstermann A., et al. Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation. Oncogene 17 22 (1998) 2933
91. Ciliberto A., Novak B., and Tyson J.J. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 4 3 (2005) 488
92. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3 2 (2003) 102